Health · 6 views
'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment
(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC), according to results from…
Summary
(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC), according to results from an early
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Your genes might boost risk for high cholesterolContinue reading
- Democrats Demand Answers From Oz After Delay in $50B Rural Health AwardsContinue reading
- Hair pulling, skin picking and nail biting are common in young people and cause significant distressContinue reading
- Can Anthropic win hearts and minds by curing hearts and minds?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow